For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260220:nRST8618Ta&default-theme=true
RNS Number : 8618T Geiger Counter Ltd 20 February 2026
Geiger Counter Limited Plc
Monthly Investor Report 20 February 2026
(All Factsheet data is at 31 January 2026)
The full monthly factsheet is now available on the Company's website and a
summary can be found below.
NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd
(https://ncim.co.uk/geiger-counter-ltd/)
Enquiries:
For the Investment Manager
Craig Cleland
Manulife CQS Investment Management
0207 201 5368
For the Company Secretary and Administrator
Summit Fund Services Jersey Limited
Chris Foulds/Katie De La Cour
01534 825341/01534 825200
-----------------------------------------------------------------------
Fund Description
The objective of Geiger Counter Limited is to provide investors with the
potential for capital growth through investment primarily in the securities of
companies involved in the exploration, development and production of energy,
predominantly within the uranium industry. Up to 30% of the value of the
Company's investment portfolio may be invested in other resource-related
companies from outside the energy sector.
Portfolio Managers
Keith Watson and Robert Crayfourd
Key Advantages for the Investor
· Access to mining assets in the uranium sector
· May benefit from embedded subscription share
· Low correlation to major asset classes
Key Fund Facts(1)
Total Gross Assets £117.7m
Reference Currency GBP
Ordinary Shares: 104,836,041
Net Asset Value 98.33p
Mid-Market Price 81.00p
Net gearing(4) 14.10%
Discount (17.62%)
Ordinary Share and NAV Performance(2)
One Month Three Months One Year Three Years Five Years
(%) (%) (%) (%) (%)
NAV 42.76 19.52 82.53 85.77 303.99
Share Price 39.66 31.71 57.89 73.26 215.18
Commentary(3)
The uranium mining sector began the year with strong momentum, reinforced by a
22% rise in the U₃O₈ spot price, which closed the month at $99/lb. Broader
commodity markets also strengthened, supported by expectations of continued
softness in the US dollar. A key catalyst for uranium was the Sprott Physical
Uranium Trust's late‑month purchase of 0.5Mlb and its activation of the
final US$1bn tranche of its US$2bn funding facility, enabling further equity
issuance to expand its already sizeable 75Mlb inventory. Sprott Physical
Uranium Trust's units briefly traded at nearly a 10% premium to NAV before
closing January at a 5% discount.
Sentiment was further supported early in the month by Meta's announcement of
agreements with several US groups to secure up to 6.6 GW of nuclear generating
capacity, drawn from both existing assets and planned new reactors, by 2035.
This coincided with US government awards totalling US$2.7bn aimed at
accelerating the development of domestic enrichment capacity.
At the World Economic Forum in Davos, the US administration reiterated its
commitment to incorporating nuclear generation into the national energy mix.
In parallel, geopolitical developments, including US actions in Venezuela,
renewed commentary on Greenland, and potential intervention in Iran, increased
investor interest across the broader energy complex, including critical
minerals such as uranium.
Against this supportive backdrop, the Company's NAV rose 42.8% in January.
This compares with sterling‑based gains of 30.4% for the Solactive Uranium
Pure Play Index and 32.9% for the Sprott Uranium Miners ETF. NexGen was the
strongest contributor, with its shares advancing more than 35% following
encouraging exploration results from a target adjacent to the Arrow project;
the Fund trimmed its position late in the month after the significant rally.
Paladin also performed strongly, gaining 44% on the back of a positive
operational update.
Gross Leverage(2) Commitment Leverage(3)
(%) (%)
Geiger Counter Ltd 115 115
CQS (UK) LLP
4th Floor, One Strand, London WC2N 5HR, United Kingdom
T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200
CQS (US), LLC
152 West 57th Street, 40th Floor, New York, NY 10019, US
T: +1 212 259 2900 | F: +1 212 259 2699
Tavistock Communications
18 St. Swithin's Lane, London EC4N 8AD
T: +44 20 7920 3150 | geigercounter@tavistock.co.uk
Sources: (1)Summit Fund Services (Jersey) Limited, as at the last business day
of the month indicated at the top of this report. (2) Summit Fund Services
Jersey Limited/DataStream, as at the last business day of the month indicated
at the top of this report, total return performance net of fees and expenses
based on bid prices. These include historic returns and past performance is
not a reliable indicator of future results. The value of investments can go
down as well as up. Please read the important legal notice at the end of this
document. (3)Market data sourced from Bloomberg unless otherwise stated. The
Company may since have exited some or all of the positions detailed in the
commentary. (4) BMO, UxC, Company data September 2023. (5) www.eia.gov
(http://www.eia.gov) . (6)CQS, as at the last business day of the month
indicated at the top of this report. For methodology details see Article 4(3)
of Directive 2011/61/EU (AIFMD) and Articles 6, 7, 9 and 10 of Delegated
Regulation 231/2013. (7)CQS, as at the last business day of the month
indicated at the top of this report. For methodology details see Article 4(3)
of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9, 10 and 11 of Delegated
Regulation 3231/2013.
The Company has announced the fifth Subscription Rights Price of 37.20 pence
on 1 May 2025. The exercise date for the fifth Subscription Right is expected
to be 30 April 2026.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DOCEAEAEALFKEFA
Copyright 2019 Regulatory News Service, all rights reserved